Skip to main content
Please enter a legal issue and/or a location
Begin typing to search, use arrow keys to navigate, use enter to select

Find a Lawyer

More Options

AstraZeneca Pharm. LP. v. Teva Pharm. USA, Inc., No. 08-1480

By FindLaw Staff on September 25, 2009 | Last updated on March 21, 2019

In a patent case involving claims for the antipsychotic drug quetiapine, district court's grant of limited motion for summary judgment of no inequitable conduct in favor of plaintiffs-AstraZeneca, is affirmed as defendants had not presented evidence sufficient for a reasonable jury to find that in the prosecution of the patent application, plaintiff made a misrepresentation of material fact or an omission of material fact, with intent to deceive or mislead the patent examiner into granting the patent.     

Read AstraZeneca Pharm. LP. v. Teva Pharm. USA, Inc., No. 08-1480

Appellate Information

Appeal from:  United States District Court for the District of New Jersey

Decided September 25, 2009


Before Newman, Rader, and Prost, Circuit Judges

Opinion by Newman, Circuit Judge.   


For Appellant:  Henry J. Renk, Fitzpatrick Cella, Harper & Scinto

For Appellee:  Ira J. Levy, Goodwin Procter LLP

You Don’t Have To Solve This on Your Own – Get a Lawyer’s Help

Meeting with a lawyer can help you understand your options and how to best protect your rights. Visit our attorney directory to find a lawyer near you who can help.

Or contact an attorney near you:
Copied to clipboard